focus -WSS

focus

author：hotspot 2025-09-28 21:04:55 - browse：26

Is biotech back from its downturn? Can Nvidia solve biology? And is it wise to do a deal on a party bus?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recording from the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit.

For more on what we cover, here’s the news on Sarepta; here’s more on Nvidia; here’s the story on Centerview; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Why medical students are struggling with mental health

explore

hotspot

WSS

CRISPR pioneers react to Casgevy, first gene

Weight loss drug costs may need more research, senator suggests

Hospitals look to new technology to keep health care workers safe

In key trial, Verve's treatment lowers cholesterol levels in patients

Opioid cravings were reduced by anti

Gain of function research would be limited under House proposal

hotspot

focus

focus

How to save PrEP access — and even expand it

Wegovy, Zepbound and weight loss drugs that preserve muscle

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

United colonoscopy coverage change 'may cost lives,' doctors say

Medicare Advantage enrollment grows 7.1% to 33.4 million people

Medicare proposal to cover medical devices draws a mixed reaction

Measles policy set amid Florida outbreak alarms vaccine proponents

hotspot

Readout Newsletter: Bayer, Rapt Therapeutics, Sanofi shortage

U.K. considers world's first use of meningitis vaccine to address gonorrhea

New study raises questions about niacin and heart health

David Sabatini, ex

Obamacare plans could cover weight loss drugs

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

explore

explore

hotspot

entertainment